| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 1 Feb 2025 | 27 Jan 2025 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 inter alia to consider and approve Un-audited financials for the quarter and nine months ended December 31 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on: 01/02/2025) | ||
| Board Meeting | 12 Nov 2024 | 6 Nov 2024 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Intimation of Board meeting scheduled to be held on November 122024. Board Meeting outcome Unaudited Financial Results Q2FY25 (As Per Bse Announcement Dated on 12.11.2024) | ||
| Board Meeting | 26 Oct 2024 | 26 Oct 2024 |
| Outcome of Board Meeting | ||
| Board Meeting | 7 Aug 2024 | 1 Aug 2024 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations as amended from time to time notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday August 7 2024 inter-alia to consider approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2024. Outcome of Board Meeting held on 07-08-2024 (As Per BSE Announcement Dated on: 07/08/2024) | ||
| Board Meeting | 30 Apr 2024 | 24 Apr 2024 |
| Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday April 30 2024 inter-alia to consider approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31 2024 and to consider recommendation of a final dividend if any on the equity shares of the Company for the financial year ended March 31 2024 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting Approval of Dividend of Rs. 2 per equity share by the Board of Directors of the Company. Outcome of Board meeting Approval of Scheme of Amalgamation of Buli Chemicals India Private Limited - WOS with Neogen Chemicals Limited- Holding company (As Per BSE Announcement Dated on 30.04.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
